MY ACCOUNT | NEWSLETTER |

Strengthening

New university findings highlight potential implications for dogs, oncology, and veterinary practice.


Select Building the Veterinary College of the Future Enhancing Capacity for Infectious Disease Research Training the Next Generation of Veterinary Clinician Scientists Strengthening "One Health" Approach to Tackling Cancer At the MSU College of Veterinary Medicine, cancer care doesn’t stop at the exam room door.

Strengthening "One Health" Approach to Tackling Cancer | College of Veterinary Medicine at MSU Support the College of Veterinary Medicine Search Tool Uncommon Will.

Our work with animal patients is helping shape how we diagnose, treat, and understand cancer across species—including people.

Many of the cancers we treat in pets—like lymphoma, melanoma, osteosarcoma, and bladder cancer—look and behave just like the cancers seen in humans.

What we learn from one patient can inform care for another.

When we treat a dog with bone cancer, for example, it can help doctors better understand the same disease in children.

And when a new imaging agent highlights a tumor in a pet, it may pave the way for earlier detection in people, too.

This is what we mean by One Health: the idea that human and animal medicine are connected—and that breakthroughs in one can lead to discoveries in the other.

MSU’s College of Veterinary Medicine is at the heart of this work.

Our clinicians and scientists lead clinical trials, advance diagnostics, and treat some of the region’s most complex cancer cases.

And because we’re part of a world-class research university, we collaborate closely with human medicine, engineering, and the life sciences—bringing broader expertise to every challenge we face.

The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.

Source university website: Michigan State University College of Veterinary Medicine

https://cvm.msu.edu/friends-alumni/uncommon-will-far-better-world/strengthening-one-health-approach-to-tackling-cancer

Event Website

https://www.avma.org/events

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

SGLT2 inhibitor therapy in diabetic cats: first clinical experiences with non-ideal candidates.

Like0
Dislike0

Faecal Microbiota Transplantation Reduces Lesion Severity and Medication Use in Canine Atopic Dermatitis: A Randomised, Placebo-Controlled, Double-Blinded Clinical Trial.

Like0
Dislike0

Dual antiplatelet therapy use after non-cardioembolic ischemic stroke or transient ischemic attack: a meta-analysis of trials and cohort studies.

Like0
Dislike0

PetPivot Brings Smart Pet-Care Technology to Philadelphia Rescue Cats Through Morris Animal Refuge Partnership

Like0
Dislike0

Computed tomographic findings in canine leproid granuloma syndrome: a case series.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top